Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704391 | SCV000529246 | benign | not provided | 2019-11-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000535582 | SCV000640839 | benign | Nemaline myopathy 2 | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000535582 | SCV002079683 | benign | Nemaline myopathy 2 | 2019-12-09 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004551474 | SCV004762217 | benign | NEB-related disorder | 2019-03-26 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |